1 / 7

Neurovascular Market - Size, Share, Growth, Current Trends, and Global Forecast 2020

Get Neurovascular Market - Strategic Analysis, Industry Research and Global Forecast, 2012 - 2020 - Neurovascular Market, Neurothrombectomy Devices, Aneurysm Coiling and Arteriovenous Malformation Embolization, Fistula Embolization, Cerebral Balloon Angioplasty, Stenting Systems, Neurothrombectomy, Carotid Artery Angiography and Stenting, Embolization of Arteriovenous Malformation Arteriovenous Fistula, Global, Market Study, Industry Overview, Segmentation Report, Future Demand, Company Strategy, Profiles, Opportunities, Sales, Growth and Forecast - Allied Market Research market research report Published by Allied Market Research. The Report is available at $4515 for Single User

ChristopherResearch
Download Presentation

Neurovascular Market - Size, Share, Growth, Current Trends, and Global Forecast 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neurovascular Market Demand and Forecast 2020

  2. SYNOPSIS The report provides market analysis, information and insights into “Neurovascular Market Demand and Forecast 2020” About Neurovascular Condition Neurovascular disease is a condition caused to nervous tissues vascular structure, neurons and blood vessels that leads to serious brain damages such as stroke, and cerebral hemorrhage. The global market for central nervous system disease was accounted to approximately $78 billion in 2010. Neurovascular disease market is mainly driven by the increase in number of patients suffering from neurological diseases. According to University of California, San Francisco (USCF), there are approximately 600,000 people suffering from stroke, out of which 10% are recovered. Almost 30% patients die due to stroke, and 60% of the patients remain disabled. View more details @ http://www.bigmarketresearch.com/neurovascular-market

  3. KEY MARKET BENEFITS: • This report offers the following benefits in particular: • Key developmental strategies adopted by top market players engaged in this business, so that companies involved in development of neurovascular device can get competitive intelligence of their competitors • Market estimation for therapeutic devices and geographic segment is derived from current market scenario and expected market trends • Market attractiveness analysis has been included for various product segments, therapeutics, devices and geographic regions with detailed analysis of factors responsible for rapid growth of the market segments • In depth analysis of key market drivers, restraints and opportunities of non-invasive diagnostic market with impact analysis • Value chain analysis, Porter’s five force model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report so that the decision makers receive clear picture of neurovascular disease treatment market

  4. KEY MARKET SEGMENTS Neurovascular Market is segmented based on , by therapeutics,devices and geography. GLOBAL MARKET, BY THERAPEUTICS • Endovascular cerebral aneurysm • Intracranial atherosclerotic disease • Chronic ischemic stroke • Acute ischemic stroke GLOBAL MARKET, BY DEVICES • Neurovascular liquid embolism • Intracranial stents & flow diverting devices • Neurovascular embolic coils • Carotid stents & embolic protection devices • Neurovascular thrombectomy devices .

  5. MARKET OVERVIEW The cost of care for these 60% patients accounted to approximately $8 billion. Cost of neurological disease treatment is lowering the growth for neurological disease. Companies are conducting clinical trials to commercialized cost effective therapies through mergers and acquisitions. Medical device manufacturing companies are facing challenges in the form of commercialization in developing countries such as India, China, and Malaysia. However, increase in research on neurovascular therapies, and favorable government policies, would give the necessary push to the neurovascular market. This report gives intelligence about current market trends available and transition of these trends in future. Market intelligence of key patents granted by respective authorities is provided in this report.

  6. SUMMARY The key companies included in this report are Medtronic, Stryker, Covidien (Ev3) , Johnson & Johnson (Micrus), Abbott Laboratories, Bayer AG, Boston Scientific Corporation, Cardiatis, S.A., Chestnut Medical Technologies, Inc., Johnson & Johnson, ITGI Medical Ltd. KEY AUDIENCES • Medical device manufacturing companies • Research based pharmaceutical companies • Academic Institutes • Government and Private research laboratories Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/22700

  7. CONTACT US Big Market Research Deep Joshi 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct : + 1-503-894-6022 Toll Free : + 1-800-910-6452 Fax : +1 (855) 550-5975 Email: help@bigmarketresearch.com Web: http://www.bigmarketresearch.com

More Related